Eli Lilly and Company (LLY) Management Presents at 82nd Scientific Sessions of the American Diabetes Association conference (Transcript)

Eli Lilly and Company (NYSE:LLY) 82nd Scientific Sessions of the American Diabetes Association conference June 7, 2022 11:30 AM ET Company Participants Lauren Zierke - Senior Director of Investor Relations Mike Mason - President of Lilly Diabetes Jeff Emmick - Vice President of Diabetes Product Development Ruth Gimeno - Vice President of Diabetes Research & Clinical Investigation Conference Call Participants Seamus Fernandez - Guggenheim Chris Schott - JPMorgan Steve Scala - Cowen Geoff Meacham - Bank of Am ...